Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038585 |
---|---|
Receipt number | R000043970 |
Scientific Title | A phase II clinical trial of neoadjuvant gemcitabine and S-1 with concurrent hypofractionated radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma |
Date of disclosure of the study information | 2019/11/14 |
Last modified on | 2019/11/14 18:45:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/11/14 18:45:32 |